Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (rapid review of technology appraisal guidance 271) - National Institute for Health and Care Excellence (NICE) (2013)
Stand: 27.10.2017